Hints and tips:
...Carlyle last year brought in Simon Dingemans, former GlaxoSmithKline chief financial officer, in its efforts to oversee UK buyouts and healthcare deals across Europe....
...Its attempted shake-up at Brentford-based healthcare group GlaxoSmithKline was blocked by the company’s board, which rejected Elliott’s demands to appoint new directors and re-evaluate whether chief executive...
...Now the firm’s president Jon Gray is looking forward to an economic reawakening....
...The consumer healthcare business, which owns brands such as Centrum vitamins and Sensodyne toothpaste, is a joint venture with Pfizer....
...US consumer industries correspondent Alistair Gray talks to Levi Strauss boss Chip Bergh about how the company has been affected by the pandemic and is finding opportunities amid the turmoil....
...They include a mix of healthcare, consumer staples and tech: GlaxoSmithKline, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L’Oréal, LVMH, AstraZeneca, SAP and Sanofi....
...But he acknowledges the wider challenge: “What they’re doing on fiscal and monetary [policy] . . . is terrific, but the real thing that they have got to solve is the healthcare crisis.”...
...Johnson & Johnson, the drug and consumer products group, managed to raise its dividend but cut its guidance for the year....
...over the activist investor Nelson Peltz’s bid to join the consumer giant's board....
...Ms Walmsley, who runs GSK’s consumer healthcare unit, will be the only female chief executive of a major global pharmaceuticals company when she takes up her new role next March....
...healthcare product sales....
...Healthcare stocks proved the favoured defensives. Shire gained 1.6 per cent to £17.96 on an upgrade from Morgan Stanley, its house broker....
...Rose Gray, co-founder, River Café. David Grey, managing director, OSL the engineering group. Anna Hemmings, canoeist. John Hick, vice-president, British Holiday and Home Parks Association....
...In the first chart, below left, you can see that client inflows, with the exception perhaps of healthcare, went into some of the riskiest sectors — financials and consumer companies....
...He already sits on the boards of GlaxoSmithKline, Oxford University and the National Trust. A decision will have to wait until after March 17....
...In the pharmaceuticals sector, GlaxoSmithKline improved 0.5 per cent to £13.71....
...As part of its strategy of focusing on core its business, the retailer earlier this year decide to sell Boots Healthcare International (BHI)....
International Edition